Interdisciplinary Nanoscience Center (iNANO), Aarhus University, Gustav Wieds Vej 14, Aarhus C, 8000, Denmark.
Adv Biosyst. 2020 Nov;4(11):e2000174. doi: 10.1002/adbi.202000174. Epub 2020 Oct 5.
Nanoformulations are widely considered in the biomedical field for drug delivery, imaging, or detoxification purposes. Cell membrane coatings are a growing concept that aims to camouflage nanomaterials. The cell membranes are the first point of contact for cells to other biological or synthetic materials and nature has established signaling pathways in this context. In contrast to using purified membrane associated proteins, the use of purified cell membranes contains the protein of interest in a very native environment. This report provides an overview over the advances in cell membrane coated (nano)particles from the past 2-3 years. The progress in using cell membranes from mammalian cells without nuclei, i.e., red blood cells and platelets, as well as nucleus-containing cells in particular white blood cell and specific cancer cells is outlined. Additionally, highlights from recent reports considering hybrid cell membrane coating that originate from at least two different cell types are discussed. Finally, a future perspective indicating the challenges and potential of cell membrane coated nanomaterials and biomaterials is provided.
纳米制剂在药物输送、成像或解毒方面在生物医学领域被广泛研究。细胞膜涂层是一个新兴的概念,旨在伪装纳米材料。细胞膜是细胞与其他生物或合成材料接触的第一点,自然界在这种情况下已经建立了信号通路。与使用纯化的膜相关蛋白相比,使用纯化的细胞膜将感兴趣的蛋白质包含在非常天然的环境中。本报告概述了过去 2-3 年中细胞膜包被(纳米)颗粒的进展。概述了使用无核哺乳动物细胞(即红细胞和血小板)以及含有核细胞(特别是白细胞和特定癌细胞)的细胞膜的进展。此外,还讨论了最近考虑至少来自两种不同细胞类型的杂交细胞膜涂层的报告中的要点。最后,提供了对细胞膜包被纳米材料和生物材料的挑战和潜力的未来展望。